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ABSTRACT Bone development is dynamically regulated by homeostasis, in which a balance 
between adipocytes and osteoblasts is maintained. Disruption of this differentiation balance 
leads to various bone-related metabolic diseases, including osteoporosis. In the present 
study, a primate-speciﬁc microRNA (miR-637) was found to be involved in the differentiation 
of human mesenchymal stem cells (hMSCs). Our preliminary data indicated that miR-637 sup-
pressed the growth of hMSCs and induced S-phase arrest. Expression of miR-637 was in-
creased during adipocyte differentiation (AD), whereas it was decreased during osteoblast 
differentiation (OS), which suggests miR-637 could act as a mediator of adipoosteogenic dif-
ferentiation. Osterix (Osx), a signiﬁcant transcription factor of osteoblasts, was shown to be 
a direct target of miR-637, which signiﬁcantly enhanced AD and suppressed OS in hMSCs 
through direct suppression of Osx expression. Furthermore, miR-637 also signiﬁcantly en-
hanced de novo adipogenesis in nude mice. In conclusion, our data indicated that the expres-
sion of miR-637 was indispensable for maintaining the balance of adipocytes and osteoblasts. 
Disruption of miR-637 expression patterns leads to irreversible damage to the balance of 
differentiation in bone marrow.
INTRODUCTION
Osteoporosis is becoming a serious public health problem, as 
global population aging accelerates. Most patients show an in-
crease in adipocytes in the bone marrow accompanied by bone loss 
(Meunier et al., 1971). Bone marrow fat cells and bone cells share a 
common progenitor, mesenchymal stem cells, that can differentiate 
into osteoblasts or adipocytes (Chamberlain et al., 2007). Both 
types of cell maintain homeostasis in the bone marrow and can 
transdifferentiate under certain conditions (Baksh et al., 2004). A 
balance between the differentiation of adipocytes and osteoblasts 
in the bone marrow must be maintained for the growth of dynamic 
connective bone tissue. With increasing age, the balance in differ-
entiation can be disrupted, and an excessive accumulation of bone 
marrow adipocytes and a decrease in bone volume are observed, 
resulting in osteoporosis (Tokuzawa et al., 2010). Therefore the bal-
ance between bone formation and bone marrow adipogenesis 
might be a therapeutic candidate for the prevention or treatment of 
osteoporosis, which exhibits deﬁcient bone formation and exces-
sive bone marrow adipogenesis (Nuttall and Gimble, 2000, 2004).
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MicroRNAs (miRNAs) are a diverse class of small, noncoding 
RNA molecules that function as negative gene regulators (Ambros, 
2004; Bartel, 2004). Although the physiological functions of most 
miRNAs are largely unknown, recent evidence has documented a 
functional contribution of speciﬁc miRNAs to stem cell differentia-
tion and development in various tissues and organs (Karp and 
Ambros, 2005; Tiscornia and Izpisúa Belmonte, 2010). Several 
miRNAs, such as miR-143, miR-378, miR-27a, miR-26a, miR-29b, 
miR-125b, miR-133, and miR-135, have been shown to be involved 
in the differentiation of adipocytes or osteoblasts (Esau et al., 2004; 
Li et al., 2008, 2009c; Luzi et al., 2008; Mizuno et al., 2008; Kim 
et al., 2009, 2010; Gerin et al., 2010). Recently, it was shown that 
overexpression of miR-204 suppressed osteoblast differentiation 
(OS) and promoted adipocyte differentiation (AD), suggesting that 
adipoosteoblast differentiation was tightly regulated by some spe-
ciﬁc miRNAs in human mesenchymal stem cell (hMSCs; Huang 
et al., 2010).
MiR-637, a primate-speciﬁc miRNA, was identiﬁed several 
years ago (Cummins et al., 2006), but no evidence of its functions 
has been documented to date. In the present study, we investi-
gated the potential involvement of miR-637 in the balance be-
tween adipocytes and osteoblasts. We also investigated the po-
tential role of miR-637 on de novo adipogenesis in a murine 
model. Finally, we explored the underlying functional mechanism 
of miR-637 in adipoosteogenic differentiation. To the best of our 
knowledge, this is the ﬁrst report to demonstrate the role of 
miR-637 in differentiation.
RESULTS
MiR-637 signiﬁcantly suppresses cell growth in hMSCs
According to microarray data, miR-638, a primate-speciﬁc miRNA 
in chromosome 19, was highly expressed in human stem cells (Li 
et al., 2009b). To investigate their functions in hMSCs, we pur-
chased all of the primate-speciﬁc miRNAs in chromosome 19, 
including miR-637, miR-638, miR-639, miR-640, miR-641, miR-
642a, and miR-643. The quantitative real-time PCR (qRT-PCR) 
results showed that the expression of miR-637 and miR-638 in 
hMSCs was remarkable (Supplemental Figure S1A). We also 
found that the expression of most miRNAs remained fairly stable 
during osteoblast differentiation (OS) and adipocyte differentia-
tion (AD); however, miR-637 was signiﬁcantly down-regulated 
during OS and up-regulated in AD at day 12 (Figure S1B). We 
postulated that miR-637 might play a role in the processes of OS 
and AD.
To study the effect of miR-637 on the differentiation of hMSCs, 
we ﬁrst examined its effect on cell growth. MiR-637, anti-miR-637, 
and a negative control (NC) were transiently transfected into hMSCs, 
and cell growth was assayed. As shown in Figure 1A, miR-637 in-
hibited cell growth in hMSCs by 23% (p < 0.01), whereas anti-
miR-637 promoted cell growth by 17% (p < 0.01). In contrast, the 
NC had no effect, indicating the effect of miR-637 was strongly 
speciﬁc.
Following the investigation of miR-637–mediated growth 
inhibition, we transfected hMSCs with miR-637 and anti-
miR-637 and examined cell cycle distribution. Compared with 
NC, hMSC cells transfected with miR-637 displayed an increased 
percentage of cells in the S phase and fewer cells in the 
G1 phase (Figure 1B; p < 0.01). In addition, no signiﬁcant differ-
ence in cell cycle distribution was observed in NC and anti-
miR-637–transfected cells. These results suggested that the 
growth-suppressive effect of miR-637 was partly due to S-phase 
arrest.
Spatial-temporal expression pattern of miR-637  
during AD and OS
To identify the effect of miR-637 on differentiation, we assayed the 
endogenous miR-637 expression pattern during AD and OS. As 
shown in Figure 2, A and B, miR-637 expression increased during 
AD and decreased during OS. The expression of DAPK3, the host 
gene of miR-637, increased during AD and decreased during OS 
(Figure 2, C and D).
In addition, we examined miR-637 expression in human bone mar-
row MSCs from two groups of individuals. The results showed that 
miR-637 expression levels were much higher in hMSCs derived from 
older subjects (>60 yr of age) who had slight or severe osteoporosis, 
than in those from younger subjects (<30 yr of age; Figure 2E).
Enforced miR-637 promoted AD and suppressed OS
Next, we used lentiviral vectors to stably restore and silence the ex-
pression of miR-637 in hMSCs (Figure S2). AD was induced in these 
infected cells and adipocytes were stronger in lentiviral pre-miR-637 
vector (Lv-miR-637)–infected and weaker in lentiviral short-hairpin 
(shRNA) of pre-miR637 vector (Lv-shmiR637)–infected cells 
(Figure 3A). Quantitative analysis of adipocytes showed that 
miR-637 promoted adipocytes by 118% (p < 0.01), while shmiR-637 
suppressed adipocytes by 27% in comparison with the lentiviral con-
trol (Lv-Ctrl; Figure 3B). Peroxisome proliferator–activated receptor 
gamma (PPAR?), the main regulator of adipogenesis, was signiﬁ-
cantly increased in Lv-miR-637–infected hMSCs, and simultaneously 
FIGURE 1: MiR-637 inhibited proliferation of hMSCs and induced cell 
arrest. (A) The effect of miR-637 on cell growth was measured by MTT 
assay on 3 serial days. (B) The representative images for cell cycle 
distribution of hMSCs transfected with miRNAs for 72 h. *, p < 0.05 
vs. NC; **, p < 0.01 vs. NC.
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early marker of osteoblasts, was shown to be decreased by 32% in 
Lv-miR-637–infected cells but increased by 22% in Lv-shmiR-637–in-
fected cells (Figure 4A). The evaluation of calcium nodules demon-
strated that Lv-miR-637 suppressed, while Lv-shmiR-637 enhanced, 
osteoblasts (Figure 4B). Moreover, the expression of bone morpho-
genic protein 2 (BMP2) and runt-related transcription factor 2 (Runx2) 
was down-regulated by Lv-miR637 but promoted by Lv-shmiR-637in 
mRNA (Figure 4C) and proteins (Figure 4D).
Osterix was a direct target of miR-637 in hMSCs
As is well known, miRNAs exert function through suppressing the 
expression of their target gene(s). To explore the mechanism under-
lying the adipoosteogenic differentiation balance maintained by 
miR-637, we performed a bioinformatics analysis using Targetscan 
(www.targetscan.org; Grimson et al., 2007), miRanda (www 
.microrna.org; Betel et al., 2010), and Findtar (http://bio.sz.tsinghua 
.edu.cn; Ye et al., 2008) for the putative mRNA targets. Although 
hundreds of different targets were predicted by each program, the 
common targets associated with adipocyte and osteoblast pre-
dicted by the three programs were Osterix (Osx) and the signal 
transducer and activator of transcription 3 (Stat3). In our biological 
experiments, the latter was demonstrated by luciferase reporter as-
says to be a pseudotarget of miR-637 (unpublished data). The three 
programs all predicted that the binding sequence in 3?UTR of Osx 
was a very good match for the miR-637 seed. To verify this predic-
tion, the target sequence (nt 387–713) of Osx 3?UTR (Wt) or the 
site-mutated sequence (Mu; the base that is underlined in Figure 5A) 
was cloned into the luciferase reporter vector pMIR (Figure 5A). 
Cos-7 cells were then cotransfected with WT vector and miRNA 
mimics, and the results showed a signiﬁcant decrease in luciferase 
activity in miR-637–transfected cells compared with NC (Figure 5B; 
p <0.01). The activity of the Mu vector was unaffected by a simulta-
neous transfection with miR-637 (Figure 5B). Moreover, cotransfec-
tion with anti-miR-637 and the WT or Mu vector had no signiﬁcant 
effect on luciferase activity (Figure 5B). Furthermore, as shown in 
Figure 5, C and D, ectopic expression of miR-637 led to a decrease 
in Osx in mRNA and proteins. Moreover, suppression of endoge-
nous miR-637 resulted in the up-regulation of Osx in hMSCs.
inhibited in Lv-shmiR-637–infected cells in mRNA and proteins 
(Figure 3C). Furthermore, other adipogenic markers, including 
CCAAT/enhancer–binding protein ? (C/EBP?) and sterol regulatory 
element–binding protein 1c (SREBP-1c), were also enhanced by Lv-
miR-637, but were down-regulated by Lv-shmiR-637 (Figure 3D).
On the other hand, we also investigated the effect of miR-637 on 
osteogenesis of hMSCs. The alkaline phosphatase (AKP) activity, an 
FIGURE 2: Spatial-temporal expression pattern of miR-637. (A) The 
endogenous expression of miR-637 was increased during AD in 
hMSCs. (B) MiR-637 expression was decreased during OS. The host 
gene, DAPK3, was up-regulated during AD (C) and down-regulated 
during OS (D). (E) MiR-637 expression was higher in bone marrow 
hMSCs from the older than the younger group (p < 0.01). *, p < 0.05 
vs. day 0; **, p < 0.01 vs. day 0.
FIGURE 3: The enforced expression of miR-637 promoted 
adipogenesis in hMSCs. (A) Adipocytes were evaluated by oil red O 
staining in Lv-Ctrl– and Lv-miR-637–infected hMSCs. Scale bar: 50 μm. 
(B) Quantitative analyses were performed by measurement of OD at 
510 nm. (C) MiR-637 promoted PPAR? expression at mRNA and 
protein levels. (D) Other adipogenic markers, such as C/EBP? and 
SREBP-1c, were promoted by miR-637. *, p < 0.05 vs. Lv-Ctrl; **,  
p < 0.01 vs. Lv-Ctrl.
FIGURE 4: The enforced expression of miR-637 suppressed 
osteoblasts in hMSCs. (A) AKP activity was measured in Lv-Ctrl– and 
Lv-miR-637–infected hMSCs. (B) Calcium nodules were displayed 
using ARS staining. (C and D) MiR-637 suppressed the expressions of 
BMP2 and Runx2 in mRNA (C) and proteins (D). *, p < 0.05 vs. Lv-Ctrl; 
**, p < 0.01 vs. Lv-Ctrl.
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twice a week for the ﬁrst 2 wk. A remarkable 
increase in adipose tissue was observed in 
nude mice following injection with Lv-miR-
637–infected hMSCs, whereas little adipose 
tissue was formed de novo with Lv-Ctrl–in-
fected hMSCs (Figure 7A). Hemotoxylin-
eosin staining revealed a striking enhance-
ment of the quantity and size of adipocytes 
induced by Lv-miR-637 (Figure 7B). Weights 
of fat pads were measured, and the results 
showed that fat formation was increased by 
miR-637 overexpression (Figure 7C). Fur-
thermore, Lv-miR-637 promoted the mRNA 
expression levels of PPAR?, C/EBP?, and 
SREBP-1c in de novo adipose tissue (Figure 
7D). It must be emphasized that these prim-
ers of PPAR?, C/EBP?, and SREBP-1c were 
human-speciﬁc. Thus miR-637 overexpres-
sion facilitated de novo adipogenesis in 
nude mice.
DISCUSSION
Osteoporosis and the increased risk of frag-
ile fractures are one of the characteristic 
manifestations of aging (Rodríguez et al., 
1999). Not only a decrease in osteoblasts, 
but also an increase in adipocytes in the 
bone marrow, may contribute to this bone-
associated metabolic disease (Meunier et al., 
1971; Koo et al., 1998). Recent studies have 
shown that bone marrow adipocytes not 
only suppress osteoblasts, but might also 
promote bone resorption by the secretion of 
inﬂammatory cytokines and the recruitment 
of osteoclasts (Weisberg et al., 2003). There-
fore, in addition to stimulating bone forma-
tion, the suppression of adipogenesis may 
be of considerable signiﬁcance for the pre-
vention and treatment of osteoporosis.
MiR-637 is a primate-speciﬁc miRNA that has been found in four 
primate species (Lin et al., 2010). Our results conﬁrmed that 
miR-637 was absent in rat and mouse MSCs (unpublished data). 
Although miR-637 was discovered several years ago, its functions, 
especially in cell death and differentiation, remain unknown. Our 
study ﬁrst demonstrated that miR-637 could moderately inhibit cell 
growth and induce S-phase arrest in hMSC cells (Figure 1). In addi-
tion, we also found that the expression of miR-637 was increased 
during AD, whereas it was decreased during OS (Figure 2). To deter-
mine the precise role of miR-637 in differentiation, we tested the 
effect of miR-637 on adipocytes and osteoblasts. Our results showed 
that miR-637 promoted the formation of adipocytes and conversely 
inhibited that of osteoblasts (Figures 3 and 4), suggesting that it 
maintained the differentiation balance between AD and OS. As a 
primate-speciﬁc miRNA, the function of miR-637 was regarded to 
be poorly conserved in rodents. Some homologous miRNAs in mice 
that act similarly to hsa (Homo sapiens)-miR-637 in hMSCs may 
exist, but we have not found such a miRNA in the miRbase (www 
.mirbase.org) to date.
Because adipogenesis and osteogenesis are very complicated 
systems in the bone marrow, to demonstrate further the function of 
miR-637 in maintaining the differentiation balance, we used a semi-
induction system to mimic the homeostasis in bone marrow as 
To further conﬁrm the positive effect of Osx on osteogenic dif-
ferentiation, small speciﬁc interfering RNA of Osx (Osx-si) was trans-
fected into hMSCs and osteogenesis was assayed. As shown in Fig-
ure 5E, AKP activity was inhibited and calcium nodules were strongly 
suppressed by Osx-si (Figure 5F).
MiR-637 maintained the balance between adipocyte  
and osteoblast differentiation
In the following experiments discussed, we imitated the adipoosteo-
genic differentiation of hMSCs using a semi-AD and semi-OS induc-
tion system as reported previously (Liu et al., 2009). As shown in 
Figure 6A, fewer red calcium nodules and more adipocyte drops (red 
drops) were observed in Lv-miR-637–infected hMSCs, which con-
trasted with the converse results observed in Lv-shmiR-637–infected 
cells. In addition, the expressions of BMP2 and Runx2 were decreased 
and PPAR? was increased in Lv-miR-637–infected cells, whereas Lv-
shmiR-637 enhanced the expression of BMP2 and Runx2 and sup-
pressed that of PPAR? in the semiinduction system (Figure 6B).
MiR-637 promoted de novo adipocytes in athymic mice
To explore whether miR-637 had an effect on adipogenesis in vivo, 
a de novo adipogenic mouse model was used. Lv-Ctrl– or Lv-
miR637–infected hMSCs were injected subcutaneously into mice 
FIGURE 5: Osx was a direct target of miR-637. (A) Schematic diagram of the predicted miR-637 
binding sites of the Osx 3?UTR-containing reporter constructs; the underlined base is the 
site-mutated sequence. (B) Luciferase reporter assays in Cos-7 cells. Luciferase reporter 
constructs containing a wild-type and site-mutated Osx 3?UTR were transfected into Cos-7 cells. 
The relative suppression of the ﬁreﬂy luciferase expression was standardized to total protein.  
(C) The mRNA expression levels of Osx were depressed by miR-637 and improved by anti-
miR-637. (D) The protein expression levels of Osx were decreased in miR-637–transfected hMSC 
cells and enhanced in anti-miR-637–transfected cells using Western blotting. (E) AKP activity was 
suppressed by Osx-si. (F) Calcium nodules were decreased by Osx-si. *, p < 0.05 vs. NC;  
**, p < 0.01 vs. NC.
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ous report, we constructed the lentiviral vector with miRNA-expres-
sion cassettes to overexpress miR-122a (Diao et al., 2010). In this 
study, we designed shRNA of miR-637 based on the stem loop of 
pre-miR-637. The constructed lentiviral pre-miR-637 and shmiR-637 
vectors easily infected more than 90% of hMSCs (Figure S2A), and 
the internal expression of mature miR-637 was strongly enforced or 
silenced (Figure S2B). Therefore successful construction of these 
vectors provided us with an efﬁcient and inexpensive way to intro-
duce miRNAs into cultured cells, which may facilitate gain-of-func-
tion and loss-of-function studies with any interest in miRNAs.
Osx, a novel zinc ﬁnger–containing transcription factor, was iden-
tiﬁed as a critical regulator of bone formation and OS (Nakashima 
et al., 2002). In humans, the Osx (Sp7) gene, like its murine ortho-
logue, showed osteoblast-speciﬁc expression in vivo (Gao et al., 
2004). Osx transcription was stimulated by BMP2 and has been 
shown to be involved in BMP2-induced OS in hMSCs (Lee et al., 
2003; Celil et al., 2005; Ryoo et al., 2006). In our studies, bioinfor-
matics analysis predicted that Osx was a direct target of miR-637and 
biological evidence demonstrated this in hMSCs (Figure 5). Osx is 
speciﬁcally expressed in all osteoblasts. As a downstream gene of 
Runx2, Osx is required for the differentiation of preosteoblasts into 
mature osteoblasts (Nishio et al., 2006). In Osx-null embryos, carti-
lage is formed normally, but the embryos totally lack bone forma-
tion (Zhang et al., 2008). Our data conﬁrmed that Osx knockdown 
suppressed osteoblasts in hMSCs, which was similar to the pheno-
types induced by miR-637 restoration. These results suggested that 
miR-637–induced differentiation was at least partly mediated by di-
rect suppression of Osx expression.
We discerned the molecular mechanism involved in the adipoos-
teogenic differentiation induced by miR-637 in an in vitro study. Fur-
thermore, ectopic de novo adipocyte differentiation was applied to 
evaluate the effect of miR-637 on adipocytes in vivo. Our data re-
vealed that Lv-miR637–infected hMSCs formed a remarkable 
amount of fat tissue and large adipocyte drops. Simultaneously, 
these cells had higher expression levels of PPAR?, C/EBP?, and 
SREBP-1c (Figure 7). Therefore miR-637 achieved beneﬁcial adipo-
cyte differentiation in hMSCs by suppressing Osx expression. This, 
therefore, suggested that miR-637 probably acted as a mediator to 
maintain the balance between AD and OS.
In conclusion, we demonstrated that 
miR-637 promoted adipocytes and sup-
pressed osteoblasts, indicating that 
miR-637 maintains the constitutive balance 
between adipogenesis and osteogenesis in 
hMSCs derived from bone marrow. When 
that balance is disrupted, adipocytes are 
stimulated and osteoblasts are suppressed. 
Therefore primate-speciﬁc miR-637 may be 
a promising therapeutic agent for osteopo-
rosis or obesity.
MATERIALS AND METHODS
Cell culture and induction of OS  
and AD 
Nine bone marrow samples from young 
subjects (<30 yr) and ﬁve bone marrow sam-
ples from older subjects (>60 yr) with slight 
or severe osteoporosis were obtained, from 
which hMSCs were isolated and identiﬁed 
by cell surface markers (Zhang et al., 2009). 
Brieﬂy, bone marrow was aspirated and 
hMSCs were cultured in minimum essential 
described previously (Liu et al., 2009). The enforced overexpression 
of miR-637 enhanced adipocytes while it decreased osteoblasts. 
Concomitantly, shmiR-637 stimulated osteogenesis and reduced 
adipogenesis (Figure 5). These ﬁndings suggested that miR-637 
could be a therapeutic candidate for osteoporosis due to its capac-
ity to maintain the balance between AD and OS.
In this paper, we describe a novel method for the knockdown of 
miR-637: the lentiviral vector with shRNA of pre-miR-637. In a previ-
FIGURE 6: MiR-637 maintained the balance between 
adipoosteogenic differentiation. (A) MiR-637 enhanced adipocytes 
and suppressed osteoblasts as visualized using ARS and oil red O 
staining, respectively. (B) The critical regulators, such as PPAR?, BMP2, 
and Runx2, were assayed by qRT-PCR. *, p < 0.05 vs. Lv-Ctrl;  
**, p < 0.01 vs. Lv-Ctrl.
FIGURE 7: MiR-637 promoted de novo adipose tissue formation in nude mice. (A) Nude mice 
were injected with Lv-Ctrl– or Lv-miR637–infected hMSCs. Fat pad sections were retrieved 6 wk 
later. (B) Hemotoxylin-eosin staining of representative sections are shown. Scale bar: 50 μm.  
(C) Quantitative analyses of fat pad weight. (D) Some regulators were analyzed. *, p < 0.05, vs. 
Lv-Ctrl; **, p < 0.01 vs. Lv-Ctrl.
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lected, and AKP activity was assayed as reported previously (Zhang 
et al., 2009).
Adipocyte assay: oil red O staining
The hMSCs were gently washed twice with phosphate-buffered sa-
line (PBS), and then ﬁxed in 4% paraformaldehyde (micrograms/
volume [ml] [m/V]) for 10 min. The samples were then washed twice 
with deionized water, and 1/3 saturated oil red O staining was 
carried out for 1 h and the samples were again washed twice. Iso-
propanol was ﬁnally added to dissolve the oil red O, and the optical 
density (OD) value was measured under 510 nm.
Mineralization assay: Alizarin Red staining
After hMSCs were ﬁxed in 4% paraformaldehyde (m/V) for 10 min, 
samples were evaluated by ARS staining. Brieﬂy, cells were stained 
with 2% Alizarin Red staining (ARS, pH 4.1) for 15 min and then 
washed twice. The orange and red positions were recognized as 
calcium nodules.
Western blotting
Cell lysates were separated by SDS–PAGE (10%) and transferred 
to polyvinylidene ﬂuoride membranes (Millipore, Billerica, MA). 
The membranes were blocked with 5% skim milk for 1 h and incu-
bated with mouse monoclonal anti-BMP2, anti- Runx2 (Abcam, 
Cambridge, MA), rabbit polyclonal anti-PPAR? (Santa Cruz Biotech-
nology, Santa Cruz, CA), and anti-Osx (Santa Cruz) antibodies. This 
was then followed by incubation with the corresponding horserad-
ish peroxide-labeled IgG (1:5000) for 1 h. Finally, chemilumines-
cence (ECL; PerkinElmer) was used to visualize the results, and 
GAPDH was used as an internal control.
Luciferase assays
Luciferase assays were performed according to a previously pub-
lished protocol (He et al., 2010; Zhang et al., 2011b). In brief, the 3? 
untranslated region (UTR) of Osx (nt 387–713), and its correspond-
ing mutated 3?UTR were ampliﬁed by PCR using the primers shown 
in Table SI. The target sequences were cloned into the pMIR re-
porter vector (Promega). Cos-7 cells were seeded onto a 24-well 
plate at a density of 1 ? 105, and cotransfection was performed. The 
ﬁreﬂy luciferase activities were measured using the Luciferase Re-
porter Assay System (Promega), and each experiment was repeated 
in triplicate. The luciferase activity was normalized by total protein 
content.
De novo adipose formation model
The treatment and usage of young athymic nude mice (females, 
4–6 wk, from the Chinese University of Hong Kong) complied 
with the guidelines of the Animal Experimental Ethics Committee 
of the Chinese University of Hong Kong. Each experimental 
group consisted of ﬁve animals. hMSCs were infected with Lv-
miR-637 or the lentivirus control (Lv-Ctrl) to induce adipogenesis 
for 3 d, and were then collected and injected subcutaneously 
into the nude mice (1 ? 108 cells/mouse). Six weeks later, ﬁve 
mice from each group were killed, and transplants were retrieved, 
ﬁxed in 10% formalin overnight, and embedded in parafﬁn. Sec-
tions (5 μm) of embedded samples were stained with hemotoxylin-
eosin.
Statistical analysis
Data are expressed as mean ? SD. Statistical analysis was performed 
using the independent t test. A p value of <0.05 was considered to 
be statistically signiﬁcant.
medium, alpha, supplemented with 10% fetal bovine serum, 2 mM 
L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin, and 
were incubated in a humidiﬁed atmosphere of 5% CO2 at 37°C.
OS and AD were induced according to a published protocol (Li 
et al., 2009a; Zhang et al., 2010). OS medium was supplemented 
with 10−8 M dexamethasone, 50 μg/ml ascorbic acid 2-phosphate, 
and 10 mM glycerol 2-phosphate (Sigma-Aldrich, St. Louis, MO). 
AD medium was supplemented with 10−7 M dexamethasone, 
10 μg/ml insulin, and 0.45 mM 3-isobutyl-1-methyl-xanthine (Sigma). 
hMSCs were seeded onto a 12-well plate at a density of 5 ? 105 cells 
per well, and the culture medium was changed to OS or AD me-
dium after 24 h. The cells were then incubated at 37°C with 5% CO2, 
and the medium was changed every 3 d.
miRNA transfection
miRNAs were transfected at a concentration of 100 nM using Lipo-
fectamine 2000 (Invitrogen, Carlsbad, CA). The miR-637 mimic, a 
nonspeciﬁc negative control, anti-miR-637, and Osx-si were all pur-
chased from GenePharma (Shanghai, China).
The sequence of Osx-si was 5?UUGCCCCAAGAUGUC-
UAUAAACCCAAG3?.
Construction of lentiviral plasmid, lentivirus production  
and infection
A 295 base pair fragment of pre-miR-637 encompassing the stem 
loop was ampliﬁed and then cloned into the lentiviral vector 
pLVTHM. Another lentiviral vector for shRNA delivery of the pre-
miR-637 stem loop was obtained as described previously (Zhang 
et al., 2011a). The production and puriﬁcation of the lentivirus were 
also performed as described previously (Diao et al., 2010). A lentivi-
ral vector that expressed a scrambled RNA was used as a control. 
The packaged lentiviruses were named Lv-miR-637 and Lv-
shmiR-637, respectively.
Cell growth and cell cycle analysis
Cells were plated in 96-well plates at 3 ? 103 per well and were 
transfected with miRNAs. After transfection, the cells were cultured 
for 24, 48, and 72 h. The effect of miR-637 on cell growth and viabil-
ity was determined by the methylthiazolyldiphenyl-tetrazolium bro-
mide (MTT) assay as described previously (Tsang and Kwok, 2009). 
For cell cycle analysis, cells were plated in 6-well plates at 2 ? 105 
per well and transfected with miRNAs. At 48 h after transfection, the 
cell cycle distribution was analyzed using propidium iodide staining 
and ﬂow cytometry as described previously (Singh et al., 2004).
RNA extraction, reverse transcription, and qRT-PCR
The total RNA was extracted by using Trizol reagent (Invitrogen). For 
the miR-637 expression assay, total RNA was reversely transcribed 
using the NCode miRNA First-Strand cDNA Synthesis kit (Invitro-
gen). To measure the mRNA levels of Osx and other genes, total 
RNA was reversely transcribed using the ImProm-II Reverse Tran-
scription System (Promega, Madison, WI). All the qRT-PCR samples 
were performed using SYBR Green PCR Master Mix (Roche, India-
napolis, IN) on an Applied Biosystems 7500 Real-Time PCR System 
(Bedford, MA). The primers used are listed in Supplemental Table SI. 
U6 or glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was 
used as an endogenous control, and fold changes were calculated 
by means of relative quantiﬁcation (2−??Ct; Lu et al., 2011).
AKP analysis
hMSCs were seeded at a density of 2 ? 105 cells per well onto a 24-
well plate, and OS was induced within 24 h. Cell lysates were col-
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